Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays

[1]  John W. M. Martens,et al.  DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients , 2008, Breast Cancer Research and Treatment.

[2]  M. Wendt,et al.  Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells , 2008, Oncogene.

[3]  David R F Carter,et al.  Genome-wide H3K9 Histone Acetylation Profiles Are Altered in Benzopyrene-treated MCF7 Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[4]  A. Chambers,et al.  Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis. , 2008, Cancer genetics and cytogenetics.

[5]  D. Hume,et al.  Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. , 2007, Cancer research.

[6]  Nong Zhang,et al.  Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells , 2007, BMC Molecular Biology.

[7]  I. Gozes,et al.  Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. , 2007, The Journal of biological chemistry.

[8]  R. Lidereau,et al.  Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis , 2007, Clinical & Experimental Metastasis.

[9]  C. Livasy,et al.  Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. , 2007, Experimental and molecular pathology.

[10]  Sandya Liyanarachchi,et al.  CpG Island Methylation in a Mouse Model of Lymphoma Is Driven by the Genetic Configuration of Tumor Cells , 2007, PLoS genetics.

[11]  M. Maio,et al.  Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications , 2007, Journal of cellular physiology.

[12]  J. Issa,et al.  Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors) , 2007, Modern Pathology.

[13]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[14]  Wei Zhang,et al.  Erratum: Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients (Breast Cancer Research and Treatment DOI: 10.1007/s10549-006-9385-7) , 2007 .

[15]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[16]  E. Lander,et al.  The Mammalian Epigenome , 2007, Cell.

[17]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[18]  J. Issa,et al.  Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer , 2006, Cancer biology & therapy.

[19]  W. Jones,et al.  DNA methylation-dependent silencing of CST6 in human breast cancer cell lines , 2006, Laboratory Investigation.

[20]  L. V. van't Veer,et al.  Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. , 2006, Journal of the National Cancer Institute.

[21]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[22]  I. Cohen,et al.  NAP, a Peptide Derived from the Activity‐Dependent Neuroprotective Protein, Modulates Macrophage Function , 2006, Annals of the New York Academy of Sciences.

[23]  R. Kordek,et al.  Studies on the Methylation Status of CpG Sequences Located in Promoters of Selected Tumour Suppressor Genes in Breast Cancer Cells , 2006, Nucleosides, nucleotides & nucleic acids.

[24]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[25]  Cláudia A Rainho,et al.  CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer , 2006, BMC Cancer.

[26]  D. Rodenhiser,et al.  Epigenetics and human disease: translating basic biology into clinical applications , 2006, Canadian Medical Association Journal.

[27]  W. Loo,et al.  DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  Wei Zhao,et al.  Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. , 2005, Cancer research.

[29]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[30]  A. Giuliano,et al.  Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer , 2005, Oncogene.

[31]  Y. Kluger,et al.  Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. , 2005, Cancer research.

[32]  N. H. Khattar,et al.  Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. , 2005, Cancer letters.

[33]  A. Giuliano,et al.  Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis , 2005, Clinical Cancer Research.

[34]  T. Nakagawa,et al.  Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer. , 2005, Japanese journal of clinical oncology.

[35]  H. Mehdorn,et al.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases , 2005, Journal of Cancer Research and Clinical Oncology.

[36]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[37]  Y. Miyoshi,et al.  Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers , 2005, Clinical Cancer Research.

[38]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[39]  I. Wong,et al.  Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. , 2003, Oncology reports.

[40]  J. Issa,et al.  Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors. , 2003, Cancer genetics and cytogenetics.

[41]  Klaus Pantel,et al.  Molecular signature associated with bone marrow micrometastasis in human breast cancer. , 2003, Cancer research.

[42]  Rodrigo Lopez,et al.  Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..

[43]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[44]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[45]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[46]  A. Godwin,et al.  Hypomethylation of the Synuclein γ Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma , 2003 .

[47]  M. Marton,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[48]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[49]  T. Visakorpi,et al.  Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma , 2002, Genes, chromosomes & cancer.

[50]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[51]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[52]  D. Rodenhiser,et al.  Epigenetic contributions to cancer metastasis , 2008, Clinical and Experimental Metastasis.

[53]  T. Downey.  Analysis of a multifactor microarray study using Partek genomics solution. , 2006, Methods in enzymology.

[54]  A. Chambers,et al.  A New Model for Lymphatic Metastasis: Development of a Variant of the MDA-MB-468 Human Breast Cancer Cell Line that Aggressively Metastasizes to Lymph Nodes , 2005, Clinical and Experimental Metastasis.

[55]  K. Mimori,et al.  Identification of molecular markers for metastasis-related genes in primary breast cancer cells , 2005, Clinical & Experimental Metastasis.

[56]  R. Dickson,et al.  Of Mice and Myc: c-Myc and Mammary Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[57]  D. Welch,et al.  KISS1 metastasis suppression and emergent pathways , 2004, Clinical & Experimental Metastasis.

[58]  A. Godwin,et al.  Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. , 2003, Cancer research.